We found that most melanoma cells expressed Axl, a key marker gene for resistance to targeted therapy in human melanoma, whose expression is mostly exclusive from Mitf+ cells, consistent with previous human melanoma report (Supplementary Fig. 13b)58,60. This evidence concerns the gene MITF and melanoma.